Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis

NCT03478605 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Emesis
Vomiting
Nausea Post Chemotherapy
Nausea
Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG: Olanzapine
DRUG: Aprepitant Pill
DRUG: Ondansetron
DRUG: Dexamethasone

Sponsor

Blokhin's Russian Cancer Research Center

Collaborators

[object Object]